InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Explore the full record of transactions filed by ROBINS CHAD M, Chief Executive Officer. Insider active across 1 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 18 disclosures have been published. Total volume traded: €17.5m. The latest transaction was disclosed on 6 April 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
US$1m83,332 shares@ US$12.48570.051% mcap11.9% of flow
Common Stock
SEC:0001780649-26-000011·
€1m83,332 shares@ €12.48570.051% mcap5.9% of flow
Common Stock
SEC:0001780649-26-000011:0·
US$2m182,891 shares@ US$13.54740.12% mcap28.3% of flow
Common Stock
SEC:0001780649-26-000003·
€2m182,891 shares@ €13.54740.12% mcap14.1% of flow
Common Stock
SEC:0001780649-26-000003:0·
US$2m124,998 shares@ US$15.56230.095% mcap22.2% of flow
Common Stock
SEC:0001780649-26-000002·
€2m124,998 shares@ €15.56230.095% mcap11.0% of flow
Common Stock
SEC:0001780649-26-000002:0·
US$2m124,998 shares@ US$13.31950.081% mcap19.0% of flow
Common Stock
SEC:0001780649-26-000001·
€2m124,998 shares@ €13.31950.081% mcap9.4% of flow
Common Stock
SEC:0001780649-26-000001:0·
US$608,12335,736 shares@ US$17.01710.030% mcap6.9% of flow
Common Stock
SEC:0001780649-25-000003·
€608,12335,736 shares@ €17.01710.030% mcap3.5% of flow
Common Stock
SEC:0001780649-25-000003:0·
€86,10114,815 shares@ €5.81170.0042% mcap0.5% of flow
Common Stock
SEC:0001209191-22-017696:0·
0247,117 shares0
Common Stock
SEC:0001209191-22-017393:0·
€380,89911,742 shares@ €32.4390.019% mcap4.3% of flow
Common Stock
SEC:0001209191-21-055586·
€380,89911,742 shares@ €32.4390.019% mcap2.2% of flow
Common Stock
SEC:0001209191-21-055586:0·
€48,3751,501 shares@ €32.22870.0024% mcap0.6% of flow
Common Stock
SEC:0001209191-21-046710·
€48,3751,501 shares@ €32.22870.0024% mcap0.3% of flow
Common Stock
SEC:0001209191-21-046710:0·
€601,96019,100 shares@ €31.51620.029% mcap6.9% of flow
Common Stock
SEC:0001209191-21-041790·
€601,96019,100 shares@ €31.51620.029% mcap3.4% of flow
Common Stock
SEC:0001209191-21-041790:0·
18 of 18 declarations
About ROBINS CHAD M
Chad M. Robins is the Chief Executive Officer of Adaptive Biotechnologies Corp.
